Awareness, Care & Treatment in Obesity Management (ACTION) Study

Completed

• Conditions: Metabolism and Nutrition Disorder; Obesity

• Registration Number: NCT03223493
• Lead Sponsor: Novo Nordisk A/S

Brief Summary

The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-29
• Primary Completion: 2015-11-12
• Study Completion: 2015-11-12
• Study First Submitted: 2017-07-18
• Study First Submitted QC: 2017-07-18
• Study First Posted: 2017-07-21
• Status Verified: 2019-07
• Last Update Submitted: 2019-07-17
• Last Update Posted: 2019-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3767

Inclusion Criteria

• GENERAL POPULATION
• Agrees to AE reporting
• Age at least 18 years
• Lives in the US
• Current BMI at least 30 kg/sqm
• HEALTH CARE PROFESSIONALS
• Agrees to AE reporting
• Physician and board certified or NP/PA
• Facility located in the U.S. and not Vermont
• Spends at least 70% of time in direct patient care
• Seen at least 100 patients in past month
• Seen at least 10 patients in past month needing weight management
• In practice 2-35 years
• Not competitively employed
• Primary Care Providers
• Specialty is FP, IM, GP
• Less than 50% patients seen for obesity
• Obesity Specialists
• Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity
• In practice 2-35 years
• EMPLOYERS
• Age at least 18 years
• Works in the US
• Director, Administrator, CHRO, VP or other title
• Responsible for making or influencing decisions about health insurance or health and wellness programs
• Company employs 500 or more full-time employees
• Believes there is a weight issue at their company
• Not competitively employed

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Awareness with the care and management of obesity among people with obesity	Start of interviews day 1 until day 15	Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Awareness with the care and management of obesity among health care providers	Start of interviews day 1 until day 15	Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design
Awareness with the care and management of obesity among employer representatives	Start of interviews day 1 until day 15	Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design

Trial Locations

Locations (1)

Novo Nordisk Investigational Site; 🇺🇸 Honeoye Falls, New York, United States